Medindia

X

Cepheid Management to Present at the 7th Annual Needham Medical Technology and Biotechnology Conference and William Blair's 28th Annual Growth Stock Conference

Thursday, June 5, 2008 General News J E 4
Advertisement
SUNNYVALE, Calif., June 4 Cepheid (Nasdaq: CPHD)announced today that the Company will webcast presentations at the followinginvestor conferences:

Andrew Miller, Senior Vice President, Chief Financial Officer, DavidPersing, Executive Vice President, Chief Medical and Technology Officer, andRob Koska, Senior Vice President, Worldwide Commercial Operations, willprovide a corporate overview at each of the conferences.

In the webcast presentations, Cepheid will provide an update on its testpipeline strategy through fiscal 2013.

Live webcasts, along with accompanying presentation slides, may beaccessed on Cepheid's Web site at http://www.cepheid.com under Investors:Events: Webcasts and Presentations. A replay of the webcast presentations willbe available for 90 days following the live events. The updated investorpresentation is now available for viewing on Cepheid's Web site underInvestors.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, California, is a moleculardiagnostics company that develops, manufactures, and markets fully-integratedsystems and tests for genetic analysis in the clinical, industrial andbiothreat markets. The company's systems enable rapid, sophisticated genetictesting for organisms and genetic-based diseases by automating otherwisecomplex manual laboratory procedures. The company's easy-to-use systemsintegrate a number of complicated and time-intensive steps, including samplepreparation, DNA amplification and detection, which enable the analysis ofcomplex biological samples in its proprietary test cartridges. Through itsstrong molecular biology capabilities, the company is focusing on thoseapplications where rapid molecular testing is particularly important, such asidentifying infectious disease and cancer in the clinical market; food,agricultural, and environmental testing in the industrial market; andidentifying bio-terrorism agents in the biothreat market. Seehttp://www.cepheid.com for more information.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080129/LATU101LOGO)-- The 7th Annual Needham Medical Technology and Biotechnology Conference on June 11 at 2:30 p.m. ET at the Millennium Broadway Hotel in New York -- William Blair's 28th Annual Growth Stock Conference on June 18 at 4:50 p.m. ET at the Four Seasons Hotel in Chicago

SOURCE Cepheid
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Mylan Confirms Patent Challenge Relating to Azor(R...
S
[video] Wallst.net's '3 Minute Press Show' Feature...